Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.

BRIEF-Richter signs deal with DM Bio for biosimilar cancer medicine

October 19, 2016 6:15 AM
6 0

* Has signed an agreement with DM Bio for development and sale of biosimilar medicine trastuzumab.

* Trastuzumab designed for the treatment of an aggressive form of breast cancer as well as a form of metastatic gastric cancer.

Also read: Shell Expected to Sign Iran Oil Deal Despite Uncertainty Over Trump

Read more

Share in social networks:

Comments - 0